Ruxolitinib cream demonstrated favorable safety and efficacy in pediatric atopic dermatitis, highlighting JAK inhibitors' ...

Our top content coverage from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 highlighted ...

For those and other reasons, targeted oral therapies like Bruton tyrosine kinase inhibitors (BTKis) and the BCL-2 inhibitor ...

Jonathan Strober, MD, discusses advancements in pediatric myasthenia gravis, emphasizing the need for better treatment standards and effective patient care strategies.

Experts convened in Cleveland, Ohio, on November 11, 2025, to discuss the evolution of cardio-renal-metabolic care from ...

AI's role in early cancer detection and patient outcome improvement is significant, with tools evaluated for utility and ...

Nerandomilast, a novel anti-fibrotic agent with improved tolerability and a dual antifibrotic/immunomodulatory mechanism, ...

A central challenge in relapsed/refractory follicular lymphoma is determining a treatment sequence that maximizes current ...

Guidelines statement on biosimilars was revised to include any appropriate biosimilar for a therapy vs focusing on rituximab.

The ZENITH trial showed sotatercept significantly reduced death, transplant, or hospitalization risk in advanced PAH, leading ...

This retrospective analysis is published in Naunyn-Schmiedeberg's Archives of Pharmacology.

Nerandomilast's tolerability and dual antifibrotic/immunomodulatory mechanism directly address the critical non-adherence ...